You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Naltrexone

Showing 576 - 600 of 615
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Analgesia Trial (Hydromorphone HCL 16mg; Dilaudid SR 16mg; Naltrexone (opioid antagonist) 50mg.)

Completed
  • Analgesia
  • Hydromorphone HCL 16mg; Dilaudid SR 16mg; Naltrexone (opioid antagonist) 50mg.
  • (no location specified)
Apr 26, 2010

Alcohol Dependence Trial in Charleston (naltrexone (up to 50 mg/day) for 8 days; ondansetron (0.25 mg twice a day) for 8 days)

Completed
  • Alcohol Dependence
  • naltrexone (up to 50 mg/day) for 8 days; ondansetron (0.25 mg twice a day) for 8 days
  • Charleston, South Carolina
    Center for Drug and Alcohol Programs, Medical University of Sout
May 4, 2010

Alcoholism Trial in United States (naltrexone (Revia), acamprosate (Campral))

Completed
  • Alcoholism
  • naltrexone (Revia)
  • acamprosate (Campral)
  • New Haven, Connecticut
  • +11 more
Apr 30, 2010

Analgesia Trial (OROS® Hydromorphone HCL; OROS® Dilaudid; Dilaudid SR (slow release); Naltrexone (an opioid antagonist).)

Completed
  • Analgesia
  • OROS® Hydromorphone HCL; OROS® Dilaudid; Dilaudid SR (slow release); Naltrexone (an opioid antagonist).
  • (no location specified)
Apr 26, 2010

Tobacco Use Disorder Trial in Minneapolis (Bupropion, Bupropion + Naltrexone)

Unknown status
  • Tobacco Use Disorder
  • Minneapolis, Minnesota
    Tobacco Use Research Center, University of Minnesota
Dec 2, 2009

Alcoholism Trial in Boston (Topiramate (Topamax))

Completed
Has Results
  • Alcoholism
  • Topiramate (Topamax)
  • Boston, Massachusetts
    Boston University Dept of Psychiatry Clinical Studies Unit
Aug 30, 2010

Prurigo Nodularis Trial in Münster (Pimecrolimus, Hydrocortisone)

Completed
  • Prurigo Nodularis
  • Münster, Germany
    Department of Dermtology, University of Münster
Jul 6, 2010

Alcoholism, Depression Trial in Philadelphia (NALTREXONE, Placebo)

Completed
  • Alcoholism
  • Depression
  • NALTREXONE
  • Placebo
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Sep 21, 2009

Opiate Dependence Trial in Oslo (Go Medical Naltrexone implants)

Completed
  • Opiate Dependence
  • Go Medical Naltrexone implants
  • Oslo, Norway
    Unit for Addiction Medicine, University of Oslo
May 4, 2009

Opioid-induced Constipation Trial in Southfield (Methylnaltrexone Bromide, Placebo-Normal Saline)

Unknown status
  • Opioid-induced Constipation
  • Methylnaltrexone Bromide
  • Placebo-Normal Saline
  • Southfield, Michigan
    Providence Hospital and Medical Center
Jan 13, 2010

Smoking Trial in Providence (Naltrexone Hydrochloride, Transdermal Nicotine)

Completed
  • Smoking
  • Naltrexone Hydrochloride
  • Transdermal Nicotine
  • Providence, Rhode Island
    VA Medical Center
Jan 20, 2009

Augmentation in Tx-resistant OCD: an Open Label Trial

Completed
  • Obsessive Compulsive Disorder
    • Omaha, Nebraska
      Creighton University Department of Psychiatry
    Nov 27, 2009

    Schizophrenia, Schizoaffective Disorder, Bipolar Disorder Trial in Syracuse (long-lasting injectable naltrexone)

    Completed
    • Schizophrenia
    • +3 more
    • long-lasting injectable naltrexone
    • Syracuse, New York
    • +2 more
    Dec 10, 2008

    Alcohol Dependence Trial in Albuquerque (Acamprosate (Campral), Acamprosate)

    Unknown status
    • Alcohol Dependence
    • Albuquerque, New Mexico
      University of New Mexico
    Jul 24, 2009

    Opioid-Dependence Among Adolescents Trial in New York (buprenorphine, naltrexone, behavior therapy)

    Unknown status
    • Opioid-Dependence Among Adolescents
    • New York, New York
      Behavioral Science Research Unit, St. Luke's Hospital
    Aug 11, 2008

    Multiple Sclerosis Trial in SAn Francisco (4.5 mg Naltrexone, Naltrexone)

    Completed
    • Multiple Sclerosis
    • 4.5 mg Naltrexone
    • Naltrexone
    • SAn Francisco, California
      MS Center UCSF, Parnassus Ave, suite #908
    May 15, 2008

    Alcoholism Trial in Germany (Acamprosate or Naltrexone)

    Completed
    • Alcoholism
    • Acamprosate or Naltrexone
    • Regensburg, Bayern, Germany
    • +4 more
    Jun 26, 2008

    Borderline Personality Disorder Trial in Germany (Naltrexone)

    Terminated
    • Borderline Personality Disorder
    • Naltrexone
    • Mannheim, Baden-Würtemberg, Germany
    • +4 more
    Apr 14, 2008

    Bipolar Disorders, Schizophrenia, Schizoaffective Disorders Trial in Syracuse (injectable naltrexone, oral naltrexone)

    Completed
    • Bipolar Disorders
    • +3 more
    • injectable naltrexone
    • oral naltrexone
    • Syracuse, New York
      SUNY Upstate Medical University
    Mar 17, 2008

    Effects of Yohimbine and Naltrexone on Sexual Function

    Completed
    • Erectile Dysfunction
    • Naltrexone HCL/ Yohimbine HCL
    • Bethesda, Maryland
      National Institute of Mental Health (NIMH)
    Mar 3, 2008

    Obesity Trial in United States (naltrexone and bupropion SR)

    Completed
    • Obesity
    • naltrexone and bupropion SR
    • San Diego, California
    • +6 more
    Apr 18, 2008

    Obsessive Compulsive Disorder Trial in Ramat-Gan (Naltrexone)

    Completed
    • Obsessive Compulsive Disorder
    • Naltrexone
    • Ramat-Gan, Israel
      Chaim Sheba Medical Center
    Jan 28, 2008

    Alcohol Dependence (Primary Condition), Alcohol Abuse Trial in New York (Memantine)

    Completed
    • Alcohol Dependence (Primary Condition)
    • Alcohol Abuse
    • New York, New York
      New York State Psychiatric Institute
    Oct 7, 2008

    Alcoholism Trial in San Antonio (ondansetron (Zofran), naltrexone (ReVia), Cognitive Behavioral Therapy)

    Completed
    • Alcoholism
    • ondansetron (Zofran)
    • +2 more
    • San Antonio, Texas
      University of Texas Health Science Center
    Dec 7, 2007

    Alcoholism, Alcohol Dependence, Depression Trial in Pittsburgh (naltrexone (Revia), fluoxetine (Prozac))

    Completed
    • Alcoholism
    • +2 more
    • naltrexone (Revia)
    • fluoxetine (Prozac)
    • Pittsburgh, Pennsylvania
      Department of Psychiatry, Western Psychiatric Institute and Clin
    Dec 7, 2007